To extend human lifespan and improve overall health, scientists have been searching for effective anti-aging interventions, and they may have stumbled upon one by chance: the high blood pressure drug rilmenidine may also be effective in slowing the aging process.
Calorie restriction has been considered the most powerful method for extending lifespan across species, but its mixed results in humans and side effects have led researchers to explore alternative solutions.
Rilmenidine: A potential game changer in the fight against aging
Researchers from ETH Zurich, Harvard Medical School and the University of Liverpool, led by Professor João Pedro Magalhães, have discovered that the antihypertensive drug rilmenidine has the potential to extend lifespan and slow ageing in animals.
The study demonstrated that administering rilmenidine to both young and older animals extended lifespan and improved health indicators, mimicking the effects of calorie restriction.
Professor Magalhães, now at the University of Birmingham, emphasised the importance of these findings, saying: “With the global population ageing, the benefits of slowing ageing even slightly are enormous.”
Role of I1-imidazoline receptors
The researchers also found that rilmenidine treatment in roundworms benefited healthspan and lifespan. Nematode Mediated by the I1-imidazoline receptor nish-1.
The identification of NISH-1 as a potential target for longevity opens new avenues for future research and drug development.
I1-imidazoline receptors are a family of receptors that bind imidazoline compounds and are involved in a variety of physiological processes.
These receptors are present in both invertebrates and vertebrates, including humans. Some imidazoline compounds can bind to both receptor types, but these are distinct from the alpha2-adrenergic receptors.
I1-imidazoline receptors are present in the central nervous system, particularly the brainstem and hypothalamus, as well as in peripheral tissues such as the kidney, pancreas, and adipose tissue, where they play a role in regulating blood pressure, insulin secretion, and lipid metabolism.
I1-imidazoline receptors are the unsung heroes of physiology
Several studies have investigated the potential therapeutic applications of targeting I1-imidazoline receptors: for example, some studies suggest that activating these receptors may have antidepressant effects and may be useful in treating depression and anxiety disorders.
Other studies have investigated the role of I1-imidazoline receptors in regulating glucose homeostasis and their potential as targets for the treatment of type 2 diabetes.
However, much remains to be elucidated about the specific functions and mechanisms of I1-imidazoline receptors in different species and their potential as therapeutic targets.
Further research is needed to fully understand the role of these receptors in various physiological processes and to develop targeted therapeutics that can harness the potential of these receptors for the treatment of various conditions, including aging-related diseases.
Anti-aging effects of rilmenidine
One of the main advantages of rilmenidine is its potential future application in humans: Unlike other drugs previously studied for anti-aging purposes, rilmenidine is a widely prescribed oral antihypertensive drug with rare and non-serious side effects.
This makes it a more feasible and safer option for humans compared to calorie restriction, which has shown mixed results and side effects in human studies.
The untapped potential of pharmaceutical repurposing
Prof. Magalhães highlighted the great potential of drug repurposing to extend lifespan and healthspan, stating that “the repurposing of drugs that can extend lifespan and healthspan has great untapped potential in translational ageing science”.
This study is the first to show that rilmenidine can extend lifespan in animals, paving the way for further exploration of its potential clinical applications.
A promising step toward healthier aging
This study on rilmenidine, led by Professor João Pedro Magalhães, offers a ray of hope in the search for effective anti-ageing interventions.
By demonstrating rilmenidine’s ability to extend lifespan and improve health indicators in animals, the researchers have unlocked the potential to revolutionize the field of aging science.
As researchers continue to study the drug’s mechanism of action and potential clinical applications, the possibility of repurposing this widely prescribed antihypertensive agent for healthier aging is becoming increasingly real.
With further research and development, Rilmenidine may pave the way for a new era of accessible and effective anti-aging solutions, bringing us one step closer to the dream of a longer, healthier life.
The full study was published in the journal Senescent cells.
—–
Like this article? Subscribe to our newsletter for more fascinating articles, exclusive content and updates.
Check it out with EarthSnap, a free app brought to you by Eric Ralls and Earth.com.
—–
